SPONSOR
University of Missouri-Columbia
Total Trials
10
Recruiting
10
Phases
Phase 4
Conditions studied: AtherosclerosisPilon FractureStrokeBreast Cancer FemaleHand TransplantationPeripheral Nerve InjuriesNeurologic RehabilitationBaker Gordon SyndromeRare Neurodevelopmental ConditionsRare Neurogenetic Conditions
University of Missouri-Columbia is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Atherosclerosis, Pilon Fracture, Stroke, Breast Cancer Female.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Missouri-Columbia
How many clinical trials has University of Missouri-Columbia sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by University of Missouri-Columbia, of which 10 are actively recruiting participants. These trials cover conditions including Atherosclerosis, Pilon Fracture, Stroke. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Missouri-Columbia research focus on?
University of Missouri-Columbia clinical trials span Atherosclerosis, Pilon Fracture, Stroke, Breast Cancer Female, Hand Transplantation, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Missouri-Columbia clinical trial?
To participate in a University of Missouri-Columbia trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Missouri-Columbia trials with current recruitment status updated daily.
Clinical Trials by University of Missouri-Columbia
NCT05235464
Recruiting
High Protein Diet and Atherosclerosis
Atherosclerosis
NCT03652753 Phase 4
Recruiting
Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC)
Pilon Fracture
NCT06588647
Recruiting
Improving Participation After Stroke Self-Management-Rehabilitation
Stroke
NCT06545045
Recruiting
Cognitive Rehabilitation Following Breast Cancer Treatment
Breast Cancer Female
NCT03610763
Recruiting
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Hand Transplantation
NCT07329257
Recruiting
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
Baker Gordon Syndrome
NCT07220265
Recruiting
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
Carrier of Phenylketonuria
NCT06399952
Recruiting
Baker Gordon Syndrome Natural History Study
Rare Diseases
NCT07231484
Recruiting
Effects of Grape Consumption on the Immune-Gut Axis in Obesity
Obesity &Amp; Overweight
NCT07120347
Recruiting
Remote Sensing for ADRD-Specific Activities Identification in Older Adults
Alzheimer Disease and Related Dementias (ADRD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology